9/30/2004

Due to a lack of clarity in the original news report, a summary in Monday's FDLI SmartBrief stated that Purdue Pharma said Palladone, its recently approved analgesic, may be more difficult to misuse than OxyContin. Purdue Pharma says it does
not claim that Palladone, which has been approved by the FDA, is abuse-resistant or more difficult to misuse than OxyContin.

Full Story:

Related Summaries